Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015 for (Statement of Deviation for proceeds of Public issue, Right Issue, OIP if any not applicable to the Company for the Quarter ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colinz Laboratories Ltd has filed a compliance statement under Regulation 32 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. This regulation requires companies to report any deviation or variation in the use of funds raised through public issues, rights issues, or offer-for-sale (OIP). The company has confirmed that this provision is not applicable to it for the quarter in question, meaning it either has no ongoing public issue, rights issue, or OIP proceeds, or there are no deviations to report. This is a routine quarterly compliance disclosure and does not involve any fundraising activity or change in fund usage.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms the absence of any deviation in the use of issue proceeds, indicating nothing out of the ordinary in the company's capital-raising or fund-utilisation activities during the quarter.